文献速递泌尿生殖MR

基于位置与ADC分层优化移行带PI-RADS 3病灶穿刺

Location- and ADC-based stratification of transition zone PI-RADS 3 lesions to optimize biopsy indication.
PubMed 文献 · Abdom Radiol (NY) · 2026-07-02

该回顾性单中心研究纳入128例根治性前列腺切除术患者的218个移行带PI-RADS 3病灶,以全标本病理为参考标准。通过解剖位置和平均ADC进行风险分层并比较四种虚拟穿刺策略,发现位置联合ADC策略可减少62%穿刺且检出91%的临床有意义前列腺癌。

要点

  • 移行带PI-RADS 3病灶中,前尖部、前中部或中部尖部为位置风险阳性,癌检出率显著更高。
  • 平均ADC<0.800×10⁻³ mm²/s定义为ADC风险阳性,癌检出率为47%。
  • 位置联合ADC策略可大幅减少不必要穿刺,同时保留大多数临床有意义癌的检出。

核心结论

  • 对移行带PI-RADS 3病灶,联合解剖位置与ADC阈值可减少不必要的穿刺,同时保留临床有意义前列腺癌的检出。

研究设计与样本

  • 回顾性单中心研究,纳入2014年1月至2023年9月行根治性前列腺切除术的128例患者的218个移行带PI-RADS 3病灶。
  • 两名放射科医师在MRI上识别病灶并测量平均ADC,第三名放射科医师将影像与全标本病理进行对照。

关键影像表现/征象

  • 位于前尖部、前中部或中部尖部的病灶被归类为位置风险阳性,其癌检出率为43%,显著高于位置风险阴性病灶的4%。
  • 平均ADC<0.800×10⁻³ mm²/s的病灶被归类为ADC风险阳性,其癌检出率为47%,显著高于ADC风险阴性病灶的10%。

诊断标准与关键数值

  • 位置风险阳性定义:病灶位于前尖部、前中部或中部尖部。
  • ADC风险阳性定义:病灶平均ADC<0.800×10⁻³ mm²/s。
  • 位置风险阳性与阴性病灶的癌检出率比较:43%(28/65)对4%(6/153),p<0.001。
  • ADC风险阳性与阴性病灶的癌检出率比较:47%(15/32)对10%(19/186),p<0.001。
  • 与常规穿刺相比,位置联合ADC策略减少62%的穿刺,检出31/34个临床有意义癌病灶(91%),漏诊3/34个(9%)。

临床应用与阅片要点

  • 对移行带PI-RADS 3病灶,阅片时应记录其是否位于前尖部、前中部或中部尖部,并测量平均ADC。
  • 位置风险阳性或ADC<0.800×10⁻³ mm²/s的移行带PI-RADS 3病灶更倾向建议穿刺。
  • 位置联合ADC分层策略可在决策曲线分析中于5%-25%阈值范围内提供优于常规策略的净获益。

局限性

  • 该研究为回顾性单中心设计,样本仅来自行根治性前列腺切除术的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine whether anatomical location and apparent diffusion coefficient (ADC) risk stratification optimizes biopsy selection for PI-RADS 3 lesions in the transition zone (TZ).

METHODS: This retrospective single-center study included 218 TZ PI-RADS 3 lesions in 128 patients who underwent radical prostatectomy between January 2014 and September 2023. Two radiologists identified 218 TZ PI-RADS 3 lesions in 128 patients on MRI and measured mean ADC; a third radiologist correlated imaging findings with whole-mount histopathology. Lesions located in the anterior apex, anterior mid-gland, or middle apex were classified as Location-risk positive; lesions with mean ADC < 0.800 × 10⁻³ mm²/s were classified as ADC-risk positive. Four virtual biopsy strategies were compared (conventional, Location-based, ADC-based, and Location + ADC-based). Outcomes included cancer detection rate (CDR), biopsy burden (performed/avoided), clinically significant prostate cancer (csPCa) yield (detected/missed), positive predictive value (PPV), and net benefit on decision curve analysis (thresholds, 5-25%).

RESULTS: Mean age was 68 ± 5.9 years (median, 69; range, 50-78). Among 218 lesions, 34 (16%) were csPCa. CDR was higher in location-risk positive than negative lesions (43% [28/65] vs. 4% [6/153]; p < 0.001) and in ADC-risk positive than ADC-risk negative lesions (47% [15/32] vs. 10% [19/186]; p < 0.001). Compared with conventional biopsy, the Location + ADC-based strategy reduced biopsies by 62% while detecting 31 of 34 csPCa lesions (91%) and missing 3 of 34 csPCa lesions (9%). Both location-informed strategies showed higher net benefit than the conventional across the evaluated thresholds.

CONCLUSION: For TZ PI-RADS 3 lesions, combining anatomical location with an ADC threshold reduces unnecessary biopsies while preserving csPCa detection.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Enjoji, Edo, Kuwamura, et al. Location- and ADC-based stratification of transition zone PI-RADS 3 lesions to optimize biopsy indication. Abdom Radiol (NY). 2026. PMID: 42387179. doi:10.1007/s00261-026-05662-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。